
Grifols, S.A. GRFS
€ 7.93
1.49%
Geschäftsbericht 2024
hinzugefügt 24.01.2026
Grifols, S.A. P/S 2011-2026 | GRFS
P/S Jährlich Grifols, S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.71 | -73.9 | -99.8 | -315 | -170 | 0.45 | -322 | -472 | -3.45 K | -1.6 K | -297 |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.71 | -3.45 K | -617 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
35.6 | $ 2.62 | 28.82 % | $ 147 M | ||
|
GlaxoSmithKline plc
GSK
|
8.36 | $ 48.98 | 0.68 % | $ 173 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.51 | 7.34 % | $ 8.45 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 25.92 | -0.86 % | $ 1.26 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Galapagos NV
GLPG
|
18.9 | $ 34.61 | 0.61 % | $ 2.69 B | ||
|
Ultragenyx Pharmaceutical
RARE
|
7.11 | $ 24.45 | 4.49 % | $ 2.21 B | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 116.27 | -1.86 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 235.41 | 2.95 % | $ 5 B | ||
|
BioXcel Therapeutics
BTAI
|
2.37 | $ 1.84 | 1.66 % | $ 4.66 M | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 9.74 | -1.37 % | $ 1.55 B | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.66 | -1.85 % | $ 16.7 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.54 | $ 67.49 | -3.02 % | $ 9.03 B | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.51 | 8.41 % | $ 9.81 B | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Coherus BioSciences
CHRS
|
0.813 | $ 2.04 | 28.3 % | $ 192 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Biogen
BIIB
|
2 | $ 171.89 | -1.1 % | $ 25 B | ||
|
Bio-Path Holdings
BPTH
|
627 | - | - | $ 100 K |